The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...

The Phase I Trial data will be submitted to regulatory agencies for review for advancing the vaccine into a Phase II efficacy ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

The shocking failure of AbbVie’s emraclidine has investors questioning the Big Pharma’s long-term neuroscience strategy, ...

Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on IO Biotech (IOBT – Research Report), retaining the price target of ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...